[
covax
]
‘Will provide 200 million doses to India for first phase’: Gavi deputy CEO
By Rhythma Kaul, New Delhi
UPDATED ON JAN 19, 2021 04:09 AM IST
"The arrangement is 20% of Gavi’s total support will be provided to India, which comes to about 200 million doses. It will cost Gavi about $1.4 billion. Gavi will also provide $30 million for technical assistance.", says Anuradha Gupta.

WHO vaccine scheme may leave poor countries with no Covid-19 shots until 2024
By Reuters | Posted by Arpan Rai | Brussels
UPDATED ON DEC 16, 2020 06:46 PM IST
The World Health Organization’s COVAX programme is the main global scheme to vaccinate people in poor and middle income countries around the world against the coronavirus.

Poor countries face long wait for vaccines despite promises
By Associated Press | Posted by Ayshee Bhaduri | New Delhi
UPDATED ON DEC 15, 2020 03:50 PM IST
The ambitious initiative known as COVAX created to ensure the entire world has access to Covid-19 vaccines has secured only a fraction of the 2 billion doses it hopes to buy over the next year, has yet to confirm any actual deals to ship out vaccines and is short on cash.

G-20 summit ends with support for Covid-19 vaccines for all
By Associated Press | Posted by Shivani Kumar | Dubai
UPDATED ON NOV 23, 2020 03:19 AM IST
The two-day summit of heads of state was held virtually due to the coronavirus pandemic, which has killed at least 1.38 million people globally, with the world’s highest death tolls recorded in seven of the G-20 countries.

Global study sees India having edge in Covid-19 vaccines
By Sanchita Sharma | Hindustan Times, New Delhi
UPDATED ON NOV 02, 2020 09:26 AM IST
It will likely take three to four years to manufacture enough vaccines to cover the world’s population, but high-income countries and a few middle-income countries with manufacturing capacity such as India, have already purchased nearly 3.8 bn doses.

What is WHO’s Vaccine Insurance Scheme? All you need to know
By hindustantimes.com | Edited by Poulomi Ghosh | Hindustan Times, New Delhi
UPDATED ON OCT 30, 2020 07:34 PM IST
If anything goes wrong after the administration of a vaccine, the government of those countries under the scheme will not have to face any cost.

Very large portion of Covid-19 vaccines likely to be manufactured in India: Gates Foundation CEO
By Press Trust of India | Posted by Nilavro Ghosh | New Delhi
UPDATED ON OCT 21, 2020 01:49 PM IST
Gates Foundation CEO Mark Suzman said that the foundation had been working to support a lot of work around diagnostics as well.

Covid-19 vaccine storage issues could leave 3 billion people without access
By Associated Press | Posted by Deepali Sharma | Gampela
UPDATED ON OCT 19, 2020 04:39 PM IST
The goal of Covax is to place orders for multiple promising candidates with the aim of distributing successful ones equitably.

Mexico pays advance to guarantee purchase of Covid-19 vaccine through COVAX
By Asian News International | Posted by Kanishka Sarkar | Asian News International
UPDATED ON OCT 12, 2020 06:51 AM IST
The contract with COVAX Facility guarantees Mexico’s acquisition of enough vaccines for up to 20 percent of the population, the foreign ministry said in a statement.

Scientists question China’s ability to produce enough Covid-19 vaccine doses for export
By hindustantimes.com | Edited by Prashasti Singh | Hindustan Times, New Delhi
UPDATED ON OCT 11, 2020 10:51 AM IST
Even if the vaccine is ready soon, scientist question whether the country will be able to produce enough doses to meet its international commitment, according to a report published on science journal Nature.

China joins WHO-backed global vaccine alliance COVAX
By Sutirtho Patranobis | Hindustan Times, Beijing
UPDATED ON OCT 09, 2020 10:36 AM IST
China is now the biggest economy to join the international initiative, with the US and Russia staying out of it.

Brazil still mulling whether to join COVAX vaccine allocation plan
By Reuters| Posted by Susmita Pakrasi | Brasilia
PUBLISHED ON SEP 11, 2020 05:48 AM IST
Eduardo Pazuello said the decision was still under consideration, speaking by videoconference at a meeting of ACT, the global alliance to accelerate development, production and equitable access to Covid-19 tests, treatments and vaccines.

In talks with India to join ‘COVAX’ vaccine scheme, says WHO
By Reuters | Posted by Shivani Kumar | Geneva, Switzerland
UPDATED ON SEP 07, 2020 11:44 PM IST
We would welcome Indian participation ...India has extensive experience (with vaccines),” said Bruce Aylward in a briefing in Geneva

‘Vaccine nationalism’ would prolong coronavirus pandemic, says WHO chief Tedros
By Reuters | Posted by Prashasti Singh | Geneva
UPDATED ON SEP 04, 2020 10:30 PM IST
The WHO and the GAVI vaccine alliance are leading the COVAX facility, aimed at helping buy and distribute vaccination shots fairly around the world.

UNICEF says drugmakers can produce unprecedented vaccine quantities for Covid-19
By Reuters| Posted by Susmita Pakrasi | Reuters
PUBLISHED ON SEP 04, 2020 05:48 AM IST
UNICEF’s role is part of a Covid-19 vaccine allocation plan - known as COVAX and co-led by the World Health Organization - that aims to buy and provide equitable access to the shots. So far, 76 wealthy nations committed to joining the COVAX effort.

Vaccine group says 76 rich countries now committed to ‘COVAX’ access plan
By Reuters| Posted by Susmita Pakrasi | London
UPDATED ON SEP 03, 2020 09:24 AM IST
Seth Berkley, chief executive of the GAVI vaccines alliance, said the coordinated plan, known as COVAX, now has Japan, Germany, Norway and more than 70 other nations signed up, agreeing in principle to procure Covid-19 vaccines through the facility for their populations.

Vaccine alliance eyes range of prices for Covid shots, says $40 would be maximum
By Reuters | Posted by Shivani Kumar | London/Chicago
UPDATED ON JUL 28, 2020 12:25 AM IST
Seth Berkley, chief executive of the GAVI vaccine alliance, which is co-leading the COVAX facility designed to ensure fair global access to Covid-19 shots, said the facility had no specific target price and would also seek to negotiate tiered pricing for richer and poorer countries.